Progenics Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000506815

Total reported 2019–2025

$25.7M

#272 of 2,960 reporting companies — 0% of all reported industry payments

$7.06M in general payments across 24,224 records, plus $18.6M in research funding across 1,800 records.

How it breaks down

General payments $7,056,567

Research funding $18,626,838

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.